| The developmental origins of health and disease PD Gluckman, MA Hanson Early life origins of health and disease, 1-7, 2006 | 716 | 2006 |
| Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains HR Ashar, M Schoenberg Fejzo, A Tkachenko, X Zhou, JA Fletcher, ... Cell 82 (1), 57-66, 1995 | 512 | 1995 |
| Lapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivo ZA Wainberg, A Anghel, AJ Desai, R Ayala, T Luo, B Safran, MS Fejzo, ... Clinical Cancer Research 16 (5), 1509-1519, 2010 | 264 | 2010 |
| Frozen tumor tissue microarray technology for analysis of tumor RNA, DNA, and proteins MS Fejzo, DJ Slamon The American journal of pathology 159 (5), 1645-1650, 2001 | 239 | 2001 |
| Nausea and vomiting of pregnancy and hyperemesis gravidarum MS Fejzo, J Trovik, IJ Grooten, K Sridharan, TJ Roseboom, Å Vikanes, ... Nature reviews Disease primers 5 (1), 62, 2019 | 226 | 2019 |
| Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13. 3 M Pallaoro, MS Fejzo, L Shayesteh, JL Blount, GH Caughey Journal of Biological Chemistry 274 (6), 3355-3362, 1999 | 188 | 1999 |
| The psychosocial burden of hyperemesis gravidarum B Poursharif, LM Korst, MS Fejzo, KW MacGibbon, R Romero, ... Journal of Perinatology 28 (3), 176-181, 2008 | 160 | 2008 |
| High prevalence of severe nausea and vomiting of pregnancy and hyperemesis gravidarum among relatives of affected individuals MS Fejzo, SA Ingles, M Wilson, W Wang, K MacGibbon, R Romero, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 141 (1 …, 2008 | 152 | 2008 |
| Elective pregnancy termination in a large cohort of women with hyperemesis gravidarum B Poursharif, LM Korst, KW MacGibbon, MS Fejzo, R Romero, ... Contraception 76 (6), 451-455, 2007 | 147 | 2007 |
| Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum MS Fejzo, OV Sazonova, JF Sathirapongsasuti, IB Hallgrímsdóttir, V Vacic, ... Nature communications 9 (1), 1178, 2018 | 146 | 2018 |
| Symptoms and pregnancy outcomes associated with extreme weight loss among women with hyperemesis gravidarum MS Fejzo, B Poursharif, LM Korst, S Munch, KW MacGibbon, R Romero, ... Journal of women's health 18 (12), 1981-1987, 2009 | 142 | 2009 |
| Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas MS Fejzo, HR Ashar, KS Krauter, WL Powell, MS Rein, S Weremowicz, ... Genes, Chromosomes and Cancer 17 (1), 1-6, 1996 | 142 | 1996 |
| Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells GE Konecny, N Venkatesan, G Yang, J Dering, C Ginther, R Finn, ... British journal of cancer 98 (6), 1076-1084, 2008 | 127 | 2008 |
| Periostin promotes ovarian cancer angiogenesis and metastasis M Zhu, MS Fejzo, L Anderson, J Dering, C Ginther, L Ramos, JC Gasson, ... Gynecologic oncology 119 (2), 337-344, 2010 | 124 | 2010 |
| Familial aggregation of hyperemesis gravidarum Y Zhang, RM Cantor, K MacGibbon, R Romero, TM Goodwin, PM Mullin, ... American journal of obstetrics and gynecology 204 (3), 230. e1-230. e7, 2011 | 121 | 2011 |
| Risk factors, treatments, and outcomes associated with prolonged hyperemesis gravidarum PM Mullin, CY Ching, F Schoenberg, K MacGibbon, R Romero, ... The Journal of Maternal-Fetal & Neonatal Medicine 25 (6), 632-636, 2012 | 109 | 2012 |
| POSTN/TGFBI-associated stromal signature predicts poor prognosis in serous epithelial ovarian cancer BY Karlan, J Dering, C Walsh, S Orsulic, J Lester, LA Anderson, ... Gynecologic oncology 132 (2), 334-342, 2014 | 108 | 2014 |
| Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer JA Byrne, RL Balleine, MS Fejzo, J Mercieca, YE Chiew, Y Livnat, ... International journal of cancer 117 (6), 1049-1054, 2005 | 108 | 2005 |
| The hD52 (TPD52) gene is a candidate target gene for events resulting in increased 8q21 copy number in human breast carcinoma RL Balleine, MS Fejzo, P Sathasivam, P Basset, CL Clarke, JA Byrne Genes, Chromosomes and Cancer 29 (1), 48-57, 2000 | 107 | 2000 |
| Posttraumatic stress symptoms following pregnancy complicated by hyperemesis gravidarum J Christodoulou-Smith, JI Gold, R Romero, TM Goodwin, KW MacGibbon, ... The Journal of Maternal-Fetal & Neonatal Medicine 24 (11), 1307-1311, 2011 | 99 | 2011 |
